Harpoon Therapeutics, Inc. (HARP)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
02-Jul-20 7:18 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 01-Jul-20Planned Private Option Sale 10,000$16.20$161,989.00(16%)
62.67K to 52.67K
02-Jul-20 7:18 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 01-Jul-20Option Exercise 10,000$0.60$6,000.0019%
52.67K to 62.67K
29-May-20 4:32 PM
View: 
Arix Bioscience Plc
10% Owner
Harpoon Therapeutics, Inc. (HARP) 28-May-20Private Sale 366,591$21.33$7,820,930.00(14%)
2.56M to 2.19M
29-May-20 4:32 PM
View: 
Arix Bioscience Plc
10% Owner
Harpoon Therapeutics, Inc. (HARP) 27-May-20Private Sale 12,064$22.39$270,144.00(< 1%)
2.57M to 2.56M
20-May-20 6:34 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 18-May-20Planned Private Option Sale 1,522$14.77$22,478.60(3%)
47.28K to 45.75K
20-May-20 6:34 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 18-May-20Option Exercise 1,522$2.12$3,226.643%
45.75K to 47.28K
13-May-20 8:45 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 12-May-20Planned Private Option Sale 1,400$14.09$19,720.00(3%)
54.07K to 52.67K
13-May-20 8:45 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 12-May-20Option Exercise 1,400$0.60$840.003%
52.67K to 54.07K
11-May-20 9:37 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 11-May-20Planned Private Option Sale 1,000$14.07$14,065.10(2%)
53.67K to 52.67K
11-May-20 9:37 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 11-May-20Option Exercise 1,000$0.60$600.002%
52.67K to 53.67K
11-May-20 9:37 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 08-May-20Option Exercise 1,000$0.60$600.002%
52.67K to 53.67K
11-May-20 9:37 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 08-May-20Planned Private Option Sale 1,000$14.00$14,000.00(2%)
53.67K to 52.67K
11-May-20 9:37 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 07-May-20Planned Private Option Sale 5,350$14.13$75,575.70(9%)
58.02K to 52.67K
11-May-20 9:37 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 07-May-20Option Exercise 5,350$0.60$3,210.0010%
52.67K to 58.02K
05-May-20 4:35 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 01-May-20Option Exercise 5,826$2.12$12,351.1013%
45.75K to 51.58K
05-May-20 4:35 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 01-May-20Market Option Sale (Planned) 5,826$12.07$70,301.20(11%)
51.58K to 45.75K
30-Apr-20 4:58 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 28-Apr-20Planned Private Option Sale 1,250$14.05$17,565.00(2%)
53.92K to 52.67K
30-Apr-20 4:58 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 28-Apr-20Option Exercise 1,250$0.60$750.002%
52.67K to 53.92K
17-Apr-20 7:10 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 17-Apr-20Option Exercise 1,021$2.12$2,164.522%
45.75K to 46.77K
17-Apr-20 7:10 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 17-Apr-20Market Option Sale (Planned) 1,021$12.08$12,330.10(2%)
46.77K to 45.75K
17-Apr-20 7:10 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 16-Apr-20Market Option Sale (Planned) 500$12.00$6,000.00(1%)
46.25K to 45.75K
17-Apr-20 7:10 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 16-Apr-20Option Exercise 500$2.12$1,060.001%
45.75K to 46.25K
15-Apr-20 4:48 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 13-Apr-20Option Exercise 4,556$2.12$9,658.7210%
45.75K to 50.31K
15-Apr-20 4:48 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 13-Apr-20Market Option Sale (Planned) 4,556$12.06$54,959.00(9%)
50.31K to 45.75K
08-Apr-20 6:10 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 07-Apr-20Option Exercise 570$2.12$1,208.401%
45.75K to 46.32K
08-Apr-20 6:10 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 07-Apr-20Market Option Sale (Planned) 570$12.00$6,840.00(1%)
46.32K to 45.75K
08-Apr-20 6:10 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 06-Apr-20Market Option Sale (Planned) 700$12.00$8,400.98(2%)
46.45K to 45.75K
08-Apr-20 6:10 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 06-Apr-20Option Exercise 700$2.12$1,484.002%
45.75K to 46.45K
18-Mar-20 5:28 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 17-Mar-20Option Exercise 1,520$2.12$3,222.403%
45.75K to 47.27K
18-Mar-20 5:28 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 17-Mar-20Market Option Sale (Planned) 1,520$12.00$18,240.00(3%)
47.27K to 45.75K
18-Mar-20 5:28 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 16-Mar-20Market Option Sale (Planned) 1$12.00$12.00(< 1%)
45.76K to 45.75K
18-Mar-20 5:28 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 16-Mar-20Option Exercise 1$2.12$2.12< 1%
45.75K to 45.76K
03-Mar-20 9:31 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 02-Mar-20Option Exercise 5,826$2.12$12,351.1013%
45.75K to 51.58K
03-Mar-20 9:31 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 02-Mar-20Planned Private Option Sale 5,826$14.68$85,525.70(11%)
51.58K to 45.75K
20-Feb-20 5:11 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 18-Feb-20Option Exercise 1,521$2.12$3,224.523%
45.75K to 47.27K
20-Feb-20 5:11 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 18-Feb-20Planned Private Option Sale 1,521$15.00$22,815.00(3%)
47.27K to 45.75K
04-Feb-20 8:11 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 03-Feb-20Planned Private Option Sale 5,826$13.90$81,006.50(11%)
51.58K to 45.75K
04-Feb-20 8:11 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 03-Feb-20Option Exercise 5,826$2.12$12,351.1013%
45.75K to 51.58K
23-Jan-20 8:34 AM
View: 
Erbez Georgia
Chief Financial Officer
Harpoon Therapeutics, Inc. (HARP) 21-Jan-20Purchase 6,700$14.09$94,417.7014%
47.29K to 53.99K
21-Jan-20 8:05 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 16-Jan-20Option Exercise 1,521$2.12$3,224.523%
45.75K to 47.27K
21-Jan-20 8:05 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 16-Jan-20Planned Private Option Sale 1,521$14.94$22,725.00(3%)
47.27K to 45.75K
06-Jan-20 9:46 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 02-Jan-20Option Exercise 5,826$2.12$12,351.1013%
45.75K to 51.58K
06-Jan-20 9:46 PM
View: 
Sacks Natalie
Chief Medical Officer
Harpoon Therapeutics, Inc. (HARP) 02-Jan-20Planned Private Option Sale 5,826$14.18$82,600.40(11%)
51.58K to 45.75K
06-Jan-20 9:55 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 02-Jan-20Option Exercise 10,000$0.60$6,000.0019%
52.67K to 62.67K
06-Jan-20 9:55 PM
View: 
Wesche Holger
Chief Scientific Officer
Harpoon Therapeutics, Inc. (HARP) 02-Jan-20Planned Private Option Sale 10,000$14.40$143,987.00(16%)
62.67K to 52.67K
30-Dec-19 5:32 PM
View: 
Baeuerle Patrick
Director
Harpoon Therapeutics, Inc. (HARP) 27-Dec-19Private Sale (Planned) 87,379$15.98$1,396,280.00(25%)
349.51K to 262.14K
17-Dec-19 9:23 PM
View: 
Chin Mark
Director
10% Owner
Harpoon Therapeutics, Inc. (HARP) 17-Dec-19Private Sale
Duplicate
12,476$16.83$209,969.00(< 1%)
2.58M to 2.57M
17-Dec-19 7:20 PM
View: 
Arix Bioscience Plc
10% Owner
Harpoon Therapeutics, Inc. (HARP) 17-Dec-19Private Sale 12,476$16.83$209,969.00(< 1%)
2.58M to 2.57M
17-Dec-19 9:23 PM
View: 
Chin Mark
Director
10% Owner
Harpoon Therapeutics, Inc. (HARP) 16-Dec-19Private Sale
Duplicate
13,080$17.02$222,680.00(< 1%)
2.6M to 2.58M
17-Dec-19 7:20 PM
View: 
Arix Bioscience Plc
10% Owner
Harpoon Therapeutics, Inc. (HARP) 16-Dec-19Private Sale 13,080$17.02$222,680.00(< 1%)
2.6M to 2.58M